Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone-Bupropion for weight loss in schizophrenia
NCT03132571Phase 2Terminated
- Sponsor
- Yale University
- Start
- Jun 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in obesity, sponsored by Yale University. Started Jun 2017; status: terminated.
02
Drugs
naltrexone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03132571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03132571.